Symbicort is a prescription medication used for the long-term maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). It contains a combination of two active ingredients: budesonide, an inhaled corticosteroid that reduces inflammation, and formoterol, a long-acting beta-agonist (LABA) that relaxes the airway muscles. As with many brand-name medications, generic versions of Symbicort have become available, offering patients more affordable treatment options.
The Generic Versions of Symbicort
There are two main types of generic versions available for Symbicort: an authorized generic and a standard Abbreviated New Drug Application (ANDA) generic. Both are FDA-approved, ensuring they meet the same strict standards for safety and effectiveness as the original brand-name drug.
Authorized Generic (Budesonide-Formoterol)
An authorized generic is produced by the same manufacturer as the brand-name drug or a partner. It is the exact same drug product as brand-name Symbicort but is labeled with the generic name 'budesonide-formoterol'. AstraZeneca launched an authorized generic through a partner, Prasco.
Standard Generic (Breyna)
Breyna is a standard generic produced by Viatris (formerly Mylan). It contains the same active ingredients (budesonide and formoterol) in the same strength and dosage form as Symbicort. It is bioequivalent to Symbicort, meaning it works the same way and produces the same therapeutic effect, although there might be minor differences in inactive ingredients or the inhaler design.
Comparing Brand-Name and Generic Symbicort
Feature | Brand-Name Symbicort | Authorized Generic (Budesonide-Formoterol) | Standard Generic (Breyna) |
---|---|---|---|
Active Ingredients | Budesonide and Formoterol | Budesonide and Formoterol | Budesonide and Formoterol |
Manufacturer | AstraZeneca | Prasco (in partnership with AstraZeneca) | Viatris (formerly Mylan) |
FDA Approval | Yes | Yes (by reference to brand) | Yes (March 2022) |
Bioequivalence | N/A | Yes, identical | Yes |
Delivery System | Metered-dose inhaler (pMDI) | Metered-dose inhaler (pMDI), identical to brand | Metered-dose inhaler (pMDI), may feel different |
Cost | Highest (without insurance) | Lower than brand-name | Often the lowest cost option |
Inactive Ingredients | As per brand formula | Identical to brand formula | May vary slightly |
Is generic Symbicort as effective?
Yes, generic Symbicort is considered just as safe and effective as the brand-name version. The FDA requires generic medications to be bioequivalent, delivering the same amount of active ingredients for the same therapeutic effect. While Breyna's inhaler may feel different, the medication delivery is calibrated to be therapeutically equivalent.
Important considerations when switching to a generic
- Insurance Coverage: Check with your insurance provider about coverage for specific generic versions and associated costs.
- Allergies: If you have allergies to inactive ingredients like dyes or preservatives, confirm the generic formulation is safe with your pharmacist.
- Proper Technique: Proper inhaler technique is vital for correct dosing. Ask your pharmacist for a demonstration of your specific device.
Conclusion
Generic budesonide-formoterol, including the authorized generic and Breyna, offers cost-effective alternatives to brand-name Symbicort for asthma and COPD. These FDA-approved generics are therapeutically equivalent, providing the same standard of care. Discuss options with your doctor and pharmacist to find the most suitable and affordable version. The FDA provides resources on generic drug equivalence for more information.